SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.

SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.

SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase and a nuclease that restricts HIV-1 in noncycling cells. Germ-line mutations in SAMHD1 have been described in patients with Aicardi-Goutières syndrome (AGS), a congenital autoimmune disease. In a previous longitudinal whole genome sequenci...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Clifford, R, Louis, T, Robbe, P, Ackroyd, S, Burns, A, Timbs, A, Wright Colopy, G, Dreau, H, Sigaux, F, Judde, J, Rotger, M, Telenti, A, Lin, Y, Pasero, P, Maelfait, J, Titsias, M, Cohen, DR, Henderson, S, Ross, M, Bentley, D, Hillmen, P, Pettitt, A, Rehwinkel, J, Knight, S, Taylor, J
Natura:	Journal article
Lingua:	English
Pubblicazione:	American Society of Hematology 2014

Documenti analoghi

SAMHD1, A Putative Tumour Suppressor, Is Recurrently Mutated in Chronic Lymphocytic Leukaemia, and Is Associated with Poor Risk Features
di: Clifford, R, et al.
Pubblicazione: (2012)

Restriction by SAMHD1 limits cGAS/STING-dependent innate and adaptive immune responses to HIV-1
di: Maelfait, J, et al.
Pubblicazione: (2016)

SAMHD1-dependent retroviral control and escape in mice.
di: Rehwinkel, J, et al.
Pubblicazione: (2013)

SAMHD1-dependent retroviral control and escape in mice
di: Rehwinkel, J, et al.
Pubblicazione: (2013)

A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis
di: Wing, P, et al.
Pubblicazione: (2019)

Characterisation of SAMHD1's ancestral function
di: Davenne, T
Pubblicazione: (2018)

A G1‐like state allows HIV‐1 to bypass SAMHD1 restriction in macrophages
di: Mlcochova, P, et al.
Pubblicazione: (2017)

Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.
di: Knight, S, et al.
Pubblicazione: (2012)

Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.
di: Knight, S, et al.
Pubblicazione: (2012)

Clinical‐grade validation of whole genome sequencing reveals robust detection of low‐frequency variants and copy number alterations in CLL
di: Klintman, J, et al.
Pubblicazione: (2018)

The light chain IgLV3-21 defines a new poor prognostic subgroup in chronic lymphocytic leukemia: Results of a multicenter study
di: Stamatopoulos, B, et al.
Pubblicazione: (2018)

RECONsidering sensing of cyclic dinucleotides
di: Maelfait, J, et al.
Pubblicazione: (2017)

Investigating SAMHD1 restriction of HIV-1 in stem cell-derived macrophages
di: Warner, D
Pubblicazione: (2020)

Keeping your armour intact: how HIV-1 evades detection by the innate immune system: HIV-1 capsid controls detection of reverse transcription products by the cytosolic DNA sensor cGAS.
di: Maelfait, J, et al.
Pubblicazione: (2014)

Nucleic acid sensors and programmed cell death
di: Maelfait, J, et al.
Pubblicazione: (2019)

Keeping your armour intact: How HIV-1 evades detection by the innate immune system: HIV-1 capsid controls detection of reverse transcription products by the cytosolic DNA sensor cGAS Prospects and Overviews J. Maelfait et al.
di: Maelfait, J, et al.
Pubblicazione: (2014)

Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns.
di: Schuh, A, et al.
Pubblicazione: (2012)

A comparison of the efficacy and safety of oral and intravenous fludarabine in chronic lymphocytic leukemia in the LRF CLL4 trial.
di: Dearden, C, et al.
Pubblicazione: (2011)

Screening for clinically significant non-deletional alpha thalassaemia mutations by pyrosequencing.
di: Haywood, A, et al.
Pubblicazione: (2010)

Sensing of viral and endogenous RNA by ZBP1/DAI induces necroptosis
di: Maelfait, J, et al.
Pubblicazione: (2017)

Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia
di: Quek, L, et al.
Pubblicazione: (2016)

Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration.
di: Hale, G, et al.
Pubblicazione: (2004)

State-of-the-Art Management of Patients Suffering from Chronic Lymphocytic Leukemia.
di: Clifford, R, et al.
Pubblicazione: (2012)

Viruses transfer the antiviral second messenger cGAMP between cells
di: Bridgeman, A, et al.
Pubblicazione: (2015)

Multiplex ligation-dependent probe amplification identification of 17 different beta-globin gene deletions (including four novel mutations) in the UK population.
di: Gallienne, A, et al.
Pubblicazione: (2009)

Identification of Novel Recurrent Copy Number Variations and Regions of Copy-Neutral Loss of Heterozygosity by High Resolution Genomic Array in Pre-Treatment and Relapsed B-CLL.
di: Knight, S, et al.
Pubblicazione: (2009)

Myeloid pre-leukemia and leukemia of Down syndrome
di: Cruz Hernandez, D, et al.
Pubblicazione: (2020)

A Case of T-Cell Acute Lymphoblastic Leukemia after Treatment of Acute Promyelocytic Leukemia
di: Bee, P.C., et al.
Pubblicazione: (2004)

Regulation of the stem cell leukemia (SCL) gene: a tale of two fishes.
di: Barton, L, et al.
Pubblicazione: (2001)

Acute leukemias in children with Down syndrome.
di: Zwaan, M, et al.
Pubblicazione: (2008)

Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial.
di: Pettitt, A, et al.
Pubblicazione: (2012)

Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL.
di: Guièze, R, et al.
Pubblicazione: (2015)

Co-Existence of LMPP-Like and GMP-Like Leukemia Stem Cells In Acute Myeloid Leukemia
di: Goardon, N, et al.
Pubblicazione: (2010)

Co Existence of LMPP Like and GMP Like Leukemia Stem Cells In Acute Myeloid Leukemia
di: Goardon, N, et al.
Pubblicazione: (2010)

Co Existence of LMPP Like and GMP Like Leukemia Stem Cells In Acute Myeloid Leukemia
di: Goardon, N, et al.
Pubblicazione: (2010)

Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.
di: Goardon, N, et al.
Pubblicazione: (2011)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
di: Reinhardt, K, et al.
Pubblicazione: (2010)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
di: Reinhardt, K, et al.
Pubblicazione: (2010)

Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV(mut) and IgHV(unmut) subgroups
di: Burns, A, et al.
Pubblicazione: (2017)

Down syndrome preleukemia and leukemia.
di: Maloney, K, et al.
Pubblicazione: (2014)